SCHEMBL30248

SCHEMBL30248

NC(=O)C1=CC=CSN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5495092 0.98
SCHEMBL4757408 0.82
SCHEMBL8119696 0.78
Benzothiophene SCHEMBL10671323 0.78 CTNNB1 (0.33)
SCHEMBL6224411 0.70
SCHEMBL16466271 0.67 CA2 (0.40)
SCHEMBL4852622 0.65
SCHEMBL6542443 0.64
SCHEMBL3707107 0.64
SCHEMBL2365680 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3174 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240041935-A1 PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS CREATIVE MEDICAL TECHNOLOGIES, INC. (US) 2024-02-08 US claimed
US-20200323883-A1 METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS ENTERIN, INC. (US) 2020-10-15 US claimed
US-10478444-B2 Methods and compositions for treating and preventing viral infections ENTERIN, INC. (US) 2019-11-19 US claimed
US-20180133230-A1 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS ENTERIN LABORATORIES, INC. (US) 2018-05-17 US claimed
US-20140328792-A1 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING VIRAL INFECTIONS ENTERIN, INC. 2014-11-06 US claimed
EP-1916994-B1 MANUFACTURING OF QUICK RELEASE PHARMACEUTICAL COMPOSITION OF WATER INSOLUBLE DRUGS AND PHARMACEUTICAL COMPOSITIONS OBTAINED BY THE PROCESS OF THE INVENTION TAKEDA PHARMA AS (DK) 2013-12-11 EP claimed
US-8361492-B2 Drug delivery system and methods of use Ocugenics, LLC (US) 2013-01-29 US claimed
US-20120183600-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS CHEN CHIEN-HUNG (US) 2012-07-19 US claimed
EP-2413917-A2 DRUG DELIVERY SYSTEM AND METHODS OF USE Ocugenics, Llc (US) 2012-02-08 EP claimed
WO-2011083291-A1 COMBINATIONS COMPRISING AN ANT I -INFLAMMATORY AGENT AND/OR AN ANTIBACTERIAL AGENT AND A GLYCOSYLAMINE AND THEIR USE IN MEDICINE GALVEZ JULIAN MANUEL (AR) 2011-07-14 WO claimed
EP-0792371-A4 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO INC (US) 1998-12-30 EP claimed
US-5811078-A IN A SOLVENT MIXTURE WITH ETHYL OR ISOPROPYL ALCOHOL AND WATER ADOLOR CORPORATION (US) 1998-09-22 US claimed
EP-0852494-A2 PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1998-07-15 EP claimed
WO-1998022090-A1 TREATMENT OF EQUINE LAMINITIS MORTAR & PESTLE VETERINARY PHARMACY, INC. (US) 1998-05-28 WO claimed
EP-0792371-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-09-03 EP claimed
EP-0786999-A1 COMBINATION METHOD FOR ACNE TREATMENT Merck & Co., Inc. (US) 1997-08-06 EP claimed
WO-1997009973-A2 PERIPHERALLY ACTIVE ANTI-HYPERALGESIC OPIATES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-03-20 WO claimed
US-5543417-A 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent MERCK & CO., INC. (US) 1996-08-06 US claimed
WO-1996012487-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed
WO-1996012817-A1 COMBINATION METHOD FOR ACNE TREATMENT MERCK & CO., INC. (US) 1996-05-02 WO claimed